State-of-the-Art Review: Antiplatelet Agents and Thrombin Inhibitors: Combined Modality Therapy

Dale J. , Myhre E. , Storstein O. , Stormoken H. , Efskind L. Prevention of arterial thromboembolism with acetylsalicylic acid: a controlled clinical study in patients with aortic ball valves. Am Heart J 1977; 94:101-111.

Chesebro JH , Fuster V. , Eleveback LR , et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole . Am J Cardiol 1983; 51:1537-41.

Meade TW , Roderick PJ , Brennan PJ , et al. Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation. Thromb Haemost 1992; 68:1-6.

Turpei Agg , Gent M. , Laupacis A. , et al. A comparison of aspirin with placebo in patients treated with warfarin after heart valve replacement. N Engl J Med 1993;329:524-9.

Altman R. , Rouvier J. , Gurfinkel E. , et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991;101:427-31.

Cannegieter SC , Rosendaal FR , Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-41.

Isom OW , Spencer FC , Glassman E. , et al. Long-term results in 1375 patients undergoing valve replacement with the Starr-Edwards cloth-covered steel ball prosthesis, Ann Surg 1977;186:310-23.

Cannegieter SC , Rosendaal FR , Wintzen AR , et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-7.

Altman R. , Boullon F. Rouvier J. , et al. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg 1976;72:127-9.

Hayashi JI , Nakazawa S. , Oguma F. , et al. Combined warfarin and antiplatelet therapy after St. Jude medical valve replacement for mitral valve disease. J Am Coll Cardiol 1994;23:672-7.

Lewis HD , Davis JW , Archibald DG , et al. Protective effect of aspirin against acute myocardial infarction and death in men with unstable angina: results of Veterans' Administration Cooperative Study. N Engl J Med 1983;309:396-403.

Cairns JA , Gent M. , Singer J. , et al. Aspirin, Sulphinpyrazone, or both in unstable angina. Results of a Canadian. multicentre trial. N Engl J Med 1985;3013:1369-75.

Theroux P. , Waters D. , Lam J. , et al. Reactivation of unstable angina following discontinuation of heparin . N Engl J Med 1992;327:141-5.

Neri Serneri GG , Gensini GF , Poggesi L. , et al. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory-unstable angina. Lancet 1990;335:615-8.

The RISC group. Risk of myocardial infarction and death during treatment with low-dose aspirin and intravenous heparin in men with unstable coronary disease. Lancet 1990;336: 827-30.

Williams DO , Kirby MG , McPherson K. , et al. Anticoagulant treatment in unstable angina. Br J Clin Pract 1986;40:114-6.

Cohen M. , Adams PC , Parry G. , et al. Combination of antithromboric therapy in unstable rest angina and non-Q-wave . infarction in nonprior aspirin users, Primary end analysis from the ATACS trial. Circulation 1994;89:81-88.

Topol EJ , Fuster V. , Harrington RA , et al. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial. Circulation 1994;89-.1557-66.

Second International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-60.

Antiplatelet Trialists Collaboratiom Collaborative overview of randomized trials of antiplatelet therapy: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-106.

The Sixty Plus Reinfarction Study Research Group. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1980; 2:989-94.

Smith P. , Amesen H. , Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction . N Engl J Med 1990;323:147-52.

Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long-term anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994; 343:499-503.

O'Donnel CJ , Ridker PM , Hebert PR , Hennekens CH Antithrombotic therapy for acute myocardial infarction. J Am Coll Cardiol 1992;25(suppl):23S-9S.

Neri Serneri GG , Rovelli F. , Gensini GF , et al. Effectiveness of low-dose heparin in prevention of myocardial reinfarction. Lancet 1987;1:937-42.

Goodman SG , Langer A. , Durica SS , et al. Safety and anticoagulation effect of low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Am J Cardiol 1994;74:657-61.

Cannon CP , McCabe CH , Henry TD , et al. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI 5) Trial. J Am Coll Cardiol 1994:23:993-1003.

Neuhaus KL , Niederer W. , Wagner J. , et al. HIT (hirudin for the improvement of thrombolysis): results of a dose escalation study [Abstract]. Circulation 1993;88:1-292.

Lee V. , for the TIMI 6 Investigators. Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the TIMI 6 trial . Am J Cardiol 1995;75:7-13.

Antman EM , for the TIMI 9A Investigators. Hirudin in acute myocardial infarction: safety report from the Thrombin and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial. Circulation 1994;90:1624-30.

The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. A randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 1994;90:1631-7.

Neuhaus KL , von Essen R. , Tebbe U. , et al. Safety observations from the pilot phase of a randomized trial: r-Hirudin for Improvement of Thrombolysis (HIT-III) Study. A study of the Arbeitsgemeinschaft Leitender, Kardiologischer Koinkenhausarzte (ALKK). Circulation 1994;90:1638-42.

Califf RM , Willerson JT Percutaneous transluminal coronary angioplasty: prevention of occlusion and restenosis. In: Fuster V. , Verstraete M. eds. Thrombosis in cardiovascular disease. Philadelphia: WB Saunders , .1992;389-408.

Thornton MA , Gruentzing AR , Hollman J. , et al. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study . Circulation 1984; 69:721-7.

Van de Bos AA , Deckers JW , Heyndricks GR , et al. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty. Circulation 1993;88(pt 1):2058-66.

Serruys P. , Herrman JP , Simon N. , et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 1995 ;333:757-63.

The Palmaz-Schatz Stent Study Group. Long-term angiographic and clinical outcome after implantation of balloon-expandable stent in the native coronary circulation. J Am Coll Cardiol 1994;24:1207-12.

Colombo A. , Hall P. , Nakamura S. , et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.